UMCCTS and Cubist Pharmaceuticals, Inc.
Developmental Therapeutics Awards 2014
To All UMass Worcester Faculty and Cubist Pharmaceutical Employees:
The UMCCTS, in collaboration with Cubist Pharmaceuticals, Inc., is announcing a special round of the Pilot Project Program (PPP) focused on understanding aspects of host-pathogen relationships that may lead to the development of novel measures to prevent or manage infectious diseases.
In this inaugural pilot program between UMCCTS and Cubist, a total of $350,000 is available to fund pilot projects (n = 2-4). Individual project awards of up to $120,000 over two years are allowed. Awards are expected to be made on a competitive basis by a scientific review committee to enable teams of joint investigators to accelerate the translation of innovative, cutting-edge research on host-pathogen interactions related to infectious diseases.
The next UMCCTS and Cubist Pharmaceutical solicitation is pending and will be announced at a future date...
The most recent funding announcement can be downloaded here.